WS MANAGEMENT LLLP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 285 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.

Quarter-by-quarter ownership
WS MANAGEMENT LLLP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$842,547
-22.5%
26,6460.0%0.07%
-25.3%
Q2 2023$1,086,624
+9.4%
26,6460.0%0.09%
-13.3%
Q1 2023$993,096
+6.8%
26,6460.0%0.10%
+31.2%
Q4 2022$929,679
-37.6%
26,6460.0%0.08%
-40.7%
Q3 2022$1,491,000
+8.1%
26,6460.0%0.14%
+20.5%
Q2 2022$1,379,000
-28.8%
26,6460.0%0.11%
+17.9%
Q1 2022$1,936,000
-38.6%
26,6460.0%0.10%
-62.2%
Q4 2021$3,151,000
-11.9%
26,6460.0%0.25%
-33.6%
Q3 2021$3,575,000
-17.1%
26,6460.0%0.38%
-11.3%
Q2 2021$4,314,000
+34.5%
26,646
-33.3%
0.43%
+27.9%
Q1 2021$3,208,000
+40.3%
39,969
-4.9%
0.33%
+40.5%
Q4 2020$2,286,000
+173.8%
42,0180.0%0.24%
+163.3%
Q3 2020$835,000
-5.4%
42,0180.0%0.09%
-16.7%
Q2 2020$883,000
+46.7%
42,018
-14.6%
0.11%
+63.6%
Q1 2020$602,000
-20.6%
49,230
-4.8%
0.07%
+1.5%
Q4 2019$758,000
+9.9%
51,7000.0%0.06%
+20.4%
Q3 2019$690,000
-26.6%
51,700
-9.9%
0.05%
-11.5%
Q2 2019$940,000
-14.2%
57,392
-10.6%
0.06%
-7.6%
Q1 2019$1,096,000
+10.3%
64,168
-11.9%
0.07%
+37.5%
Q4 2018$994,000
-71.1%
72,798
-39.3%
0.05%
-57.5%
Q3 2018$3,434,000
+4.6%
120,0000.0%0.11%
+21.5%
Q2 2018$3,283,000120,0000.09%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders